News

Turmeric is a spice with antioxidant and anti-inflammatory properties. It may help to treat various types of pain, including ...
The approval is supported by strong preclinical data demonstrating MP1032's capacity to sustain muscle function.
A new study from scientists at Scripps Research suggests that a drug already approved by the FDA to treat inflammation could help people with alcohol use disorder (AUD) by reducing both alcohol ...
With inflammation being the cause of dry eye in many cases, future treatment will likely target this aspect of dry eye.
(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs ...
In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid ...
Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
The drug candidate exerts its anti-inflammatory activity upstream of currently approved NSAIDs, which target the LOX-COX pathway. Initially, Edesa’s EB05 work focused on ARDS driven by influenza ...